SP-MHCI-0952-2

SARS-CoV-2 ORF3a protein 139-147, LLYDANYFL

US$169.00

In stock

Description

About SARS-CoV-2 ORF3a protein 139-147, LLYDANYFL

The SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) ORF Protein 3a Peptide (IEDB: 1311180) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The ORF Protein Peptide, H-LLYDANYFL-OH (Uniprot: P0DTC3 aa: 139-147) from JPT is produced under strict quality control and quality management.

SARS-CoV-2 ORF3a protein 139-147, LLYDANYFL - Specifications

  • Peptide sequence: H-LLYDANYFL-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Covid-19
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for SARS-CoV-2 ORF3a protein 139-147, LLYDANYFL

References:
Read References with JPT’s Antigen Peptides
SARS-CoV-2 ORF3a protein 139-147, LLYDANYFL has been described in:
Unbiased Screens Show CD8<sup>+</sup> T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein., Immunity, 2020 (PMID: 33128877)
Characterization of pre-existing and induced SARS-CoV-2-specific CD8<sup>+</sup> T cells., Nat Med, 2021 (PMID: 33184509)

Documentation

Documentation for SARS-CoV-2 ORF3a protein 139-147, LLYDANYFL

Properties

Properties of SARS-CoV-2 ORF3a protein 139-147, LLYDANYFL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Covid-19
Layout: Freeze-dried in glass vial
Organism: SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Protein Name: ORF Protein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to SARS-CoV-2 ORF3a protein 139-147, LLYDANYFL

Information Values
Sequence: H-LLYDANYFL-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote